Table of Contents  
ORIGINAL PAPER
Year : 2011  |  Volume : 2  |  Issue : 1  |  Page : 17-20  

The incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital


1 Department of Pharmacology, Govt. Medical College, Jagdalpur, Chhattisgarh, India
2 Department of PSM, Govt. Medical College, Jagdalpur, Chhattisgarh, India
3 Department of Medicine, Govt. Medical College, Jagdalpur, Chhattisgarh, India

Date of Web Publication25-Feb-2011

Correspondence Address:
Harminder Singh
Department of Pharmacology, Govt. Medical College, Jagdalpur (C.G)-494 001, Chhattisgarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.77095

Rights and Permissions
   Abstract 

Objective: To assess and evaluate the frequency, severity and classification of drug-related problems (DRP) resulting in hospitalization in an internal medicine department of a large tertiary care hospital and to identify any patient, prescriber, drug, and system factors associated with these events. Materials and Methods: A prospective and descriptive study carried out in Department of Medicine, Government Medical College, Jagdalpur. The DRP and relevant data were recorded on the personal record of every individual patient, filled during the course of treatment. Result: A total of 3560 patient's records were analyzed. Among them118 admissions were due to DRP. The most common DRP noted was noncompliance in part of patient's i.e 55 (46.6%). Statistically significant correlations were found in the number of prescribed drugs and over the counter drugs (OTC) used by patients. Conclusion: The DRP that attributed to hospital admission are mostly avoidable through proper patient education and strengthening the need of pharmacovigilance with little more vigilance in patient care.

Keywords: Adverse drug reactions, drug related problems, over the counter drug


How to cite this article:
Singh H, Kumar BN, Sinha T, Dulhani N. The incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother 2011;2:17-20

How to cite this URL:
Singh H, Kumar BN, Sinha T, Dulhani N. The incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother [serial online] 2011 [cited 2019 Jul 20];2:17-20. Available from: http://www.jpharmacol.com/text.asp?2011/2/1/17/77095


   Introduction Top


The uses of medications are associated with problems that involve a broad set of clinical situations and can result in significant drug-related morbidity and mortality. Over the last 40 years, advances in drug therapy has enhanced patient care but also led to a noticeable increase in the incidence of drug related problems (DRP). [1] Drugs are usually prescribed with the objective of achieving an optimal therapeutic outcome. When the outcome is not optimal, a DRP has occurred. [2],[3] Studies in developed countries showed that approximately 5% of all hospital admissions were drug related and 50% of those were avoidable. [4]

There are several predisposing factors for adverse drug reactions (ADR). These include multiple drug therapy, age, sex and polypharmacy, inter current diseases, race and genetic polymorphism. [5] Numerous studies have investigated the problem of drug-related morbidity in ambulatory care, emergency department, and hospitalized patients. [6],[7]

The World Health Organization (WHO) defines adverse drug reaction as any noxious, unintended, or undesired effect of a drug occurring at dosages administered in humans for prophylaxis, diagnosis or treatment. [8] This definition, excludes many other classifications of adverse drug events that may result in hospitalization, such as untreated indication, improper drug selection, sub therapeutic or supratherapeutic dosage, noncompliance, drug interaction, and drug use without an indication. [9] We need a more comprehensive, clinically important, and reproducible definition of adverse drug event that would result in a more accurate and meaningful characterization of drug-related hospitalization.

Most of the studies on DRP have been done internationally, so in India very limited research has been conducted to exemplify the impact of DRP that result in hospital admission although the fact is that most of these DRP are avoidable with little vigilant effort.

In this era of increased awareness to improved patient safety coupled with continuing budget restraints, accurate characterization of drug- related hospitalization is an important step towards reducing the potentially significant load that these problems place on our health care system. [10]

The purpose of this study was to prospectively evaluate the frequency, severity, and classification of adverse drug events resulting in hospitalization in an internal medicine department of a large tertiary care hospital, and to identify any patient, prescriber, drug, and system factors associated with these events.


   Materials and Methods Top


This prospective observational study was conducted at department of internal medicine, Government Medical College, Jagdalpur (Chhattisgarh) with the help of department of Pharmacology. Ethics approval was obtained from the Clinical Research Ethics Board and written consent of patients were taken as per ethical guidelines.

All patients who presented to the medicine department during a six months period from January to June 2010 were eligible for enrolment. Inclusion and exclusion criteria: All those cases requiring hospital admission to medicine department due to health problem during a six months period from January to June 2010 were included for the study. Cases which were treated from the Out Patient Departments (OPDs), and which do not require hospital stay, were excluded from the study.

Each patient was interviewed to determine the chief complaint, history of the present illness, past medical history, medication history and allergy status. Information from the physical examination conducted by the treating physician or resident, laboratory results and results of diagnostic tests were used as necessary. Patients were followed up until hospital discharge. Drug related problems were noted according to Hepler and Strand classification of drug-related problems. [11] A drug related hospitalization was defined as drug related if it was directly related to one of eight predefined classifications: adverse drug reaction, drug interaction, improper drug selection, untreated indication, subtherapeutic dosage, supratherapeutic dosage, noncompliance, and drug use without indication. [3] We used the WHO's definition of adverse drug reaction and included all reactions to drugs administered at appropriate dosages, as well as those associated with abnormal drug concentrations or laboratory values. [3]

Severity was classified as mild (laboratory abnormality or symptom not requiring treatment), moderate (laboratory abnormality or symptom requiring treatment or admission to hospital or resulting in nonpermanent disability), severe (abnormality or symptom that was life-threatening or resulted in permanent disability) or fatal. [12] Drug-related visits were defined as preventable if drug treatment or lack thereof, was inconsistent with current best practice. Such inconsistencies included inappropriate drug, dosage, route or frequency for the patients clinical condition, age, weight or renal function, known drug allergy or previous reaction to drug; known drug interaction, non-adherence, lack of laboratory monitoring and prescribing, dispensing or administration errors. [7],[13]

Data collection

Information related to the patients was collected from the patient files by using a structured questionnaire. Face-to-face enquiries were done with patients along with their attendants and also attending doctors, if required. Proper details and information regarding the matter was discussed with the concerned doctors before entrusting the responsibility. All the available medical records of the patient were studied from the patient's history. The data were analyzed by using Microsoft Excel in a computer. Data analysis has been presented in tabulated form.

Statistical analysis

We generated descriptive statistics, specifically means and standard deviations. The primary outcomes of DRP were reported as a percentage with 95% confidence interval (CI). The secondary outcome comparison was carried out using logistic regression method and chi square test to evaluate associations between drug-related visits. P< 0.05 was considered significant.


   Results Top


During the study period, 3594 patients presented to the medicine department 34 (0.9%) left the medicine department without being seen by physician or resident. Thus, we included 3560 patients (whose demographic characteristics are presented in [Table 1]) in the final analysis. The mean age of these patients was 49.8 (±18.23) years; 40% were female. Among 3560 admissions 118 were due to drug related problems. The classification of drug related admissions are given in [Table 2]. The most common drug related problem noted was noncompliance.
Table 1: Baseline data of the 3560 hospitalized patients

Click here to view
Table 2: Classification of the 118 drug related hospital admissions

Click here to view


Factors associated with drug-related hospital admission (in medicine department) and the comparisons between two populations are shown in [Table 3]. Severity was classified as mild in 19 cases (16.1%, 95% CI 9.47% to 22.7%), moderate in 91 cases (77.12%, 95% CI 69.54% to 84.70%) and severe in 08 cases (6.78%, 95% CI 2.24% to 11.32%). The few of most common drugs associated with definite DRP were oral hypoglycemic, antihypertensive, chemotherapy (especially anti retroviral agents) and insulin. Most of the definite and possible DRP were definitely preventable. Statistically significant correlations were found in number of prescribed drug and over the counter drug (OTC) used by patients. Interestingly the education status of two populations that is patients with drug related hospitalizations (n=118) and patients without drug related hospitalizations (n=3442) were found statistically significant.
Table 3: Factors associated with drug-related hospital admission in medicine department

Click here to view



   Discussion Top


In this study, we found that drug related hospital admission accounted for 3.31% medicine department admission among them 78% was considered preventable. Although 77.12% patient outcomes associated with drug-related hospitalization were moderate, 6.78% were considered severe, and 0.7% under sever category resulted in fatal outcome. Number of prescribed drug and use of OTC drugs appeared to be higher among patients whose visits were drug-related than among patients who presented for other reasons. The prospective design of this study and its large sample size increases the likelihood that our estimates of drug-related visits and related factors are accurate. Over the past few years, several published studies have addressed the problem of drug related morbidity in various practice settings. [2],[6] Studies on drug-related hospitalization have estimated that approximately 5% to 10% of all hospital admissions are drug related but in our study the percentage is quite low compared to the previous studies, which may be due to the high level of illiteracy, poverty and tribal populated area. So all the related problems have not come to the health care facilities or they may have misconception that these problems are natural course of the diseases. [7],[14],[15],[16]

Major differences concern our prospective design, in this study; patients were prospectively included on admission and were followed up until discharge. Other prospective studies identified frequencies of fatal medication related hospitalizations of 0.15% to 9%, which are comparable to present study. [12],[17] The classification and specific drug therapy associated with hospitalizations in our study are consistent with those in previous reports. Adverse drug reaction, improper drug selection, and noncompliance were the most common reasons of drug-related hospitalization in our study population. Adverse drug reaction and noncompliance have been consistently cited as the primary reasons for drug-related morbidity, regardless of study setting.

The need for direct patient contact by pharmacists and other health care team members is obvious and a collaborative and interdisciplinary patient care model is most beneficial in providing safe and effective therapy. [18] Among all DRP related admissions, non-compliance was the foremost and account for 46.6% of total admission which may have strong correlation with the illiteracy, poverty and misconceptions. Being a tribal populated area the patients started visiting providers of non-conventional therapies and may even stop conventional medications. This was an important reason for noncompliance and had not been reported in previous studies. Complicated medication regimens and inability to recall the regimen and the greater number of preparations used were other important reasons associated with increased risk of non-compliance and increased risk of a hospitalization related to non-compliance.

A factor limiting the scope of this study was the fact that our study involved patients admitted to an internal medicine unit, so a significant number of patients with minor DRP who were not admitted may have been missed from OPD, emergency and other major departments. Future research should focus on interventions to explore the way by which one can ensure higher admission rate among patients with drug-related visits and optimal strategy that may involve interventions outside the hospital to improve prescribing practices and monitoring, particularly among high-risk patients or patients taking high-risk medications or patient on polypharmacy. [19] Our results once again highlight the need of well known principle of pharmacovigilance with simpler regimens with fewer pills to be taken each day as well a well established pharmacy to link between medical practitioner and the patients to make them more vigilant towards the drug they consume and reporting the adverse effects immediately to the concern authority.

 
   References Top

1.Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharmaceut J 2003;270:583-6.  Back to cited text no. 1
    
2.Patel P, Zed PJ. Drug-related visits to the emergency department: How big is the problem? Pharmacotherapy 2002;22:915-23.  Back to cited text no. 2
[PUBMED]    
3.Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.  Back to cited text no. 3
[PUBMED]    
4.Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.  Back to cited text no. 4
[PUBMED]    
5.Lee A, Thomas SH. Pharmacovigilance. In: Walker R, Edwards C, editors. Clinical Pharmacy and Therapeutics. 3rd Ed. London: Churchill Livingstone; 2003. p. 33-46.  Back to cited text no. 5
    
6.Winterstein AG, Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R, Kanjanarat P. Nature and causes of clinically significant medication errors in a tertiary care hospital. Am J Health Syst Pharm 2004;61:1908-16.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Zed PJ. Drug-related visits to the emergency department. J Pharm Pract 2005;18:329-35.  Back to cited text no. 7
    
8.World Health Organization. International drug monitoring: The role of the hospital. Geneva: World Health Organization; 1996. (Technical report series: No 425.)  Back to cited text no. 8
    
9.van Mil JW, Westerlund LT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67.  Back to cited text no. 9
[PUBMED]  [FULLTEXT]  
10.Forster AJ, Shojania KG, van Walraven C. Improving patient safety: moving beyond the "hype"of medical errors. CMAJ 2005;173:893-4.  Back to cited text no. 10
[PUBMED]  [FULLTEXT]  
11.Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy 2004;24:1491-8.  Back to cited text no. 11
[PUBMED]  [FULLTEXT]  
12.Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as a cause of admission to hospital: Prospective analysis of 18820 patients. BMJ 2004;329:15-9.  Back to cited text no. 12
[PUBMED]  [FULLTEXT]  
13.Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170:345-9.  Back to cited text no. 13
[PUBMED]  [FULLTEXT]  
14.Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug Reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-6.  Back to cited text no. 14
[PUBMED]  [FULLTEXT]  
15.Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Adverse drug reactions in a department of systemic disease-oriented internal medicine: Prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000;56:181-6.  Back to cited text no. 15
    
16.Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36:1092-8.  Back to cited text no. 16
[PUBMED]    
17.Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 2007;34:494-8.  Back to cited text no. 17
[PUBMED]  [FULLTEXT]  
18.English, Tom. Drug-related problems: Once a $76.6 billion headache, now a $177.4 billion migraine. Pharma Today 2001;7:1-10.  Back to cited text no. 18
    
19.Shojania KG. Safe medication prescribing and monitoring in the outpatient setting. CMAJ 2006;174:1257-9.  Back to cited text no. 19
[PUBMED]  [FULLTEXT]  



 
 
    Tables

  [Table 1], [Table 2], [Table 3]


This article has been cited by
1 Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period
O. Ferrández,S. Grau,O. Urbina,S. Mojal,M. Riu,E. Salas
Saudi Pharmaceutical Journal. 2018;
[Pubmed] | [DOI]
2 Categorization and association analysis of risk factors for adverse drug events
Lina Zhou,Anamika Paul Rupa
European Journal of Clinical Pharmacology. 2017;
[Pubmed] | [DOI]
3 Prevalence of Drug-Related Emergency Department Visits at a Teaching Hospital in Malaysia
Abubakar Ibrahim Jatau,Myat Moe Thwe Aung,Tuan Hairulnizam Tuan Kamauzaman,Ab Fatah Ab Rahman
Drugs - Real World Outcomes. 2015; 2(4): 387
[Pubmed] | [DOI]
4 Application of drug-related problem (DRP) classification systems: a review of the literature
Benjamin J. Basger,Rebekah J. Moles,Timothy F. Chen
European Journal of Clinical Pharmacology. 2014;
[Pubmed] | [DOI]
5 Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia
Mohamed Al-Arifi,Hanan Abu-Hashem,Mohamed Al-Meziny,Ragab Said,Hisham Aljadhey
Saudi Pharmaceutical Journal. 2013;
[Pubmed] | [DOI]
6 Systemic review on drug related hospital admissions – A pubmed based search
Kolli Nivya,Vempati Sri Sai Kiran,Nandita Ragoo,B. Jayaprakash,M. Sonal Sekhar
Saudi Pharmaceutical Journal. 2013;
[Pubmed] | [DOI]
7 Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities—A Systematic-Review
Kerry Wilbur,Huda Hazi,Aya El-Bedawi,Giuseppe Biondi-Zoccai
PLoS ONE. 2013; 8(6): e66803
[Pubmed] | [DOI]
8 Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities-A Systematic-Review
Wilbur, K. and Hazi, H. and El-Bedawi, A.
PLoS ONE. 2013; 8(6)
[Pubmed]
9 Comparative study of antimicrobial activity of leaves and callus extract of ipomea turpethum against antibiotic resistance pathogenic microorganisms
Rathnan, R.K. and Jose, F. and Pius, I. and Sathar, L. and Jimmy, N. and Sasidharan, S. and Mechoor, A.
Research Journal of Pharmacy and Technology. 2012; 5(6): 805-808
[Pubmed]
10 Phytochemical analysis and in vitro antimicrobial activity of Illicium griffithii Hook. f. & Thoms extracts
Vijayakumar, A. and Duraipandiyan, V. and Jeyaraj, B. and Agastian, P. and Raj, M.K. and Ignacimuthu, S.
Asian Pacific Journal of Tropical Disease. 2012; 2(3): 190-199
[Pubmed]
11 Evaluation of antibacterial and antifungal activity of root and root callus extracts of Trianthema decandra L
Radfar, M. and Sudarshana, M.S. and Kavitha, H.U. and Satish, S. and Niranjan, M.H.
African Journal of Biotechnology. 2012; 11(2): 510-515
[Pubmed]



 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Materials and Me...
    Results
    Discussion
    References
    Article Tables

 Article Access Statistics
    Viewed2918    
    Printed186    
    Emailed0    
    PDF Downloaded661    
    Comments [Add]    
    Cited by others 11    

Recommend this journal